Telangiectatic Osteosarcoma, from the CureRays guide library.

Telangiectatic osteosarcoma is a rare, high-grade bone cancer made largely of blood-filled spaces that can be mistaken for a benign cyst; treated like conventional osteosarcoma with chemotherapy before and after surgery, its outlook is now similar to that of standard osteosarcoma.

What it is.

Telangiectatic osteosarcoma is an uncommon variant of osteosarcoma, the most common cancer that starts in bone. Its defining feature is that much of the tumor is made of large, blood-filled spaces, which on scans and even at surgery can look like a benign, blood-filled cyst called an aneurysmal bone cyst. This resemblance can cause delays or misdiagnosis, so expert review is important — the giveaway is the presence of malignant, high-grade cells lining and within those spaces. Like conventional osteosarcoma, it most often arises around the knee (the lower thigh bone or upper shin bone) in teenagers and young adults, and it can weaken the bone enough to cause a fracture. Despite its dramatic, bloody appearance, it is treated on exactly the same successful path as conventional high-grade osteosarcoma: chemotherapy first to shrink the tumor and treat microscopic spread, then limb-sparing surgery to remove it, then more chemotherapy. Older reports suggested a poor outlook, but with modern chemotherapy its survival is now similar to that of conventional osteosarcoma, and how well the tumor responds to the initial chemotherapy is an important predictor of long-term success.

How radiation treats it.

Radiation damages the DNA inside cancer cells so they can no longer divide and survive, while healthy cells are better at repairing themselves. Telangiectatic osteosarcoma is treated mainly with chemotherapy and surgery; osteosarcoma cells are relatively resistant to ordinary radiation, so radiation is not a routine part of care. When a tumor cannot be completely removed or sits in a difficult location such as the spine or pelvis, specialized high-dose particle beams (proton or carbon-ion) may be used to deliver a strong dose while sparing nearby tissue. Whenever radiation is given, it is delivered as short, painless daily sessions and leaves no radioactivity in your body, so you remain safe to be around family and children.

The ways we can treat it.

Chemotherapy. Combination chemotherapy circulates through the body to shrink the tumor and destroy microscopic spread; it is given both before and after surgery.

Surgery. Wide resection removes the tumor with a cuff of normal tissue, usually with a limb-sparing reconstruction; the removed specimen is examined to measure chemotherapy response.

Radiation (limited role). Osteosarcoma resists ordinary radiation, so it is not routine; it may be considered for tumors that cannot be fully removed or sit in difficult locations such as the spine or pelvis, sometimes with particle beams.

Questions we hear often.

My scan was first called a benign cyst — could it still be cancer? Yes, which is why expert review matters. Telangiectatic osteosarcoma is full of blood-filled spaces and can look just like a benign aneurysmal bone cyst on imaging. A sarcoma pathologist looks for the malignant, high-grade cells that confirm cancer and change the treatment.

Is the outlook really as bad as older information suggests? No. Decades-old reports described a poor prognosis, but with today's chemotherapy the survival of telangiectatic osteosarcoma is similar to that of conventional osteosarcoma. How well the tumor responds to the first round of chemotherapy is an important sign of how things will go.

Will I lose my limb? Usually not. Most patients have limb-sparing surgery, where the tumor is removed and the bone reconstructed. Amputation is reserved for situations where clear margins cannot otherwise be achieved safely.

This guide is informational only. It is not medical advice — please confirm anything here with your care team.